PEF1
Peflin
Also known as: PEF1_HUMAN, PEF1A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBV8
- Gene
- PEF1
- Ensembl
- ENSG00000162517
- Chromosome
- 1
- Canonical length
- 284 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes a calcium-binding protein belonging to the penta-EF-hand protein family. The encoded protein has been shown to form a heterodimer with the programmed cell death 6 gene product and may modulate its function in Ca(2+) signaling. Alternative splicing results in multiple transcript variants and a pseudogene has been identified on chromosome 1.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
284 residues, UniProt reviewed canonical sequence.
>Q9UBV8|PEF1
1 MASYPYRQGC PGAAGQAPGA PPGSYYPGPP NSGGQYGSGL PPGGGYGGPA PGGPYGPPAG
61 GGPYGHPNPG MFPSGTPGGP YGGAAPGGPY GQPPPSSYGA QQPGLYGQGG APPNVDPEAY
121 SWFQSVDSDH SGYISMKELK QALVNCNWSS FNDETCLMMI NMFDKTKSGR IDVYGFSALW
181 KFIQQWKNLF QQYDRDRSGS ISYTELQQAL SQMGYNLSPQ FTQLLVSRYC PRSANPAMQL
241 DRFIQVCTQL QVLTEAFREK DTAVQGNIRL SFEDFVTMTA SRMLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PEF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 105 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 105 nTPM
- blood vessel: 91 nTPM
- choroid plexus: 88 nTPM
- skin: 82 nTPM
- epididymis: 80 nTPM
- kidney: 70 nTPM
Single-cell type
- syncytiotrophoblasts: 209 nCPM
- cytotrophoblasts: 186 nCPM
- migrating cytotrophoblasts: 181 nCPM
- esophageal apical cells: 149 nCPM
- late spermatids: 140 nCPM
- esophageal suprabasal cells: 126 nCPM
Immune cell
- basophil: 148 nTPM
- total PBMC: 105 nTPM
- eosinophil: 93 nTPM
- gdT-cell: 90 nTPM
- NK-cell: 88 nTPM
- MAIT T-cell: 87 nTPM
Brain region
- pons: 67 nTPM
- medulla oblongata: 61 nTPM
- hypothalamus: 60 nTPM
- white matter: 58 nTPM
- spinal cord: 57 nTPM
- cerebellum: 57 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.28
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- COPII vesicle coating
- endoplasmic reticulum to Golgi vesicle-mediated transport
- neural crest cell development
- neural crest formation
- positive regulation of protein monoubiquitination
- response to calcium ion
Molecular functions
- calcium ion binding
- calcium-dependent protein binding
- identical protein binding
- protein dimerization activity
- protein heterodimerization activity
- RNA binding
- ubiquitin-like ligase-substrate adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PEF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PEF1 as an antibody target. Whether an autoantibody or antibody against PEF1 could matter depends on whether native PEF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PEF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PEF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...